z-logo
open-access-imgOpen Access
Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model
Author(s) -
Jane Freeman,
Miriam Marquis,
G. S. Crowther,
S. L. Todhunter,
Warren N. Fawley,
C. H. Chilton,
Greg Moeck,
Dario Lehoux,
Mark H. Wilcox
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks309
Subject(s) - clostridium difficile , microbiology and biotechnology , clindamycin , vancomycin , spore , hamster , toxin , biology , clostridium difficile toxin a , antibiotics , pharmacology , bacteria , staphylococcus aureus , endocrinology , genetics
To evaluate the relative propensities of oritavancin and vancomycin to induce Clostridium difficile infection (CDI) in hamster and in vitro human gut models.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom